is a glp 1 a peptide sequences and molecular structures of FDA approved GLP-1 RAs Glucagon-like peptide-1: Trends in Endocrinology

But does it balance cost and safety, or just look good on the surface

New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.

Across the dataset, a few patterns stood out: Zepboundposts mention fatigue, constipation, and hair thinning more than any other drug

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why GLP-1 users stop taking the drug.